4//SEC Filing
Greenstein Leonard M. 4
Accession 0001519692-23-000006
CIK 0001819790other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 6:04 PM ET
Size
11.0 KB
Accession
0001519692-23-000006
Insider Transaction Report
Form 4
Greenstein Leonard M.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-03-15+4,462→ 38,751 total - Sale
Common Stock
2023-03-16$13.43/sh−313$4,204→ 38,438 total - Sale
Common Stock
2023-03-16$13.44/sh−5,000$67,200→ 33,438 total - Exercise/Conversion
Restricted Stock Units
2023-03-15−4,462→ 13,388 total→ Common Stock (4,462 underlying)
Footnotes (6)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs")
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.
- [F4]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.28 to $13.65. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F6]RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest in equal installments on March 15, 2023, March 15, 2024, March 15, 2025 and March 15, 2026, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001519692
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 6:04 PM ET
- Size
- 11.0 KB